Purchase Order SPE2DS26P0682
Award Date 2/13/26
Potential Completion Date 4/14/26
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chelmsford, MA 01824, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
5
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $1,266.30 firm fixed-price purchase order to Zoll Medical Corporation for an invasive blood cable on September 15, 2025, with an ultimate completion date of November 14, 2025. The contract, with no set-aside designation, will be performed at Zoll's facility in Chelmsford, Massachusetts. Zoll Medical Corporation, a foreign-owned medical device manufacturer, specializes in emergency medical technologies and critical care...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a purchase order to Zoll Medical Corporation on January 6, 2026, for invasive blood cables with a firm fixed-price ceiling value of $1,266.30 and an ultimate completion date of March 9, 2026. This contract was awarded without set-aside designation, indicating unrestricted competition. Zoll Medical Corporation, headquartered in Chelmsford, Massachusetts, is a foreign-owned medical device manufacturer specializing in...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a $2,349 firm fixed-price purchase order to Zoll Medical Corporation for an invasive blood cable on August 21, 2025. The contract, with an ultimate completion date of October 20, 2025, will be performed in Chelmsford, Massachusetts, where Zoll maintains its headquarters. This award does not utilize a small business set-aside designation. Zoll Medical Corporation, a foreign-owned medical device manufacturer...
- The U.S. Defense Department's Medical Supply Chain division awarded a $1,809 firm fixed-price purchase order to Zoll Medical Corporation for an invasive blood cable on October 2, 2025, with a completion deadline of December 1, 2025. The contract, which carries no set-aside designation, will be performed at Zoll's facility in Chelmsford, Massachusetts. Zoll Medical Corporation, a foreign-owned medical device manufacturer headquartered in Massachusetts, specializes in advanced emergency medical...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $1,053 firm fixed-price purchase order to Zoll Medical Corporation for invasive blood cables. The contract, issued on June 18, 2025, with an ultimate completion date of August 18, 2025, will be performed at Zoll's facility in Chelmsford, Massachusetts. This award does not utilize a set-aside designation and represents a discrete procurement under Zoll's existing contract relationships with the federal government. Zoll...
- Zoll Medical Corporation, a Massachusetts-based medical device manufacturer, was awarded a firm fixed-price purchase order valued at $1,809.00 by the Defense Logistics Agency's Medical Supply Chain division on October 2, 2025. The contract calls for the delivery of invasive blood cables, with performance scheduled for completion by December 1, 2025. The work will be performed at Zoll's facility in Chelmsford, Massachusetts. This award was made without a set-aside designation and represents a...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $12,214.80 firm fixed-price purchase order to Zoll Medical Corporation for invasive blood cables on November 13, 2025, with an ultimate completion date of January 12, 2026. The contract was awarded without a set-aside designation, reflecting open competition in the federal marketplace. Place of performance is located in Chelmsford, Massachusetts, where Zoll maintains its headquarters as a leading manufacturer of advanced...
- Zoll Medical Corporation has been awarded a firm fixed-price purchase order valued at $1,085.40 for invasive blood cable supplies, with an ultimate completion date of September 22, 2025. The contract was awarded on July 23, 2025, by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation, indicating open competition. The place of performance is Chelmsford, Massachusetts, where Zoll maintains its headquarters as a leading manufacturer of advanced emergency...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded Zoll Medical Corporation a $1,085.40 firm fixed-price purchase order for invasive blood cables on August 28, 2025, with an ultimate completion date of October 27, 2025. This contract was performed in Chelmsford, Massachusetts, and was not designated as a set-aside award. Zoll Medical Corporation, a foreign-owned medical device manufacturer based in Chelmsford, specializes in advanced emergency medical technologies and...
- Zoll Medical Corporation has been awarded a firm fixed-price purchase order valued at $1,447.20 for invasive blood cables, with an ultimate completion date of March 16, 2026. The contract, awarded on January 13, 2026, was issued without set-aside designation, indicating unrestricted competition. The work will be performed at Zoll's facility in Chelmsford, Massachusetts, and is funded through the Defense Logistics Agency's Medical Supply Chain division, which serves as a primary federal...
The Defense Logistics Agency Medical Supply Chain awarded a purchase order to Zoll Medical Corporation on February 13, 2026, for invasive blood cable at a firm fixed price of $1,174.50, with ultimate completion by April 14, 2026. Performance occurs in Chelmsford, Massachusetts, where Zoll manufactures medical devices. No set-aside category was applied to this purchase order.
Generated 5/14/26, 9:59 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 2/12/26 |